Particularly, WHO grade II, 1p/19q co-deletion, IDH mutation, MGMT promoter methylation, and oligodendroglioma had decreased m5CrLS scores (Figures 4D, S5A). The gene discussed is IDH1; the disease is oligodendroglioma.